Table of Content

1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.1.1. Increasing Use of Microfluidic Immunoassays in Drug Discovery & Development and Biomarker Detection Driving Market Growth
4.2.1.2. Bubble Formation and Dead Volume Limiting the Adoption of Microfluidics Devices
4.2.1.3. Increasing Demand for Point-of-Care Testing Generating Growth Opportunities for Market Players
4.2.1.4. Selecting Suitable Substrate Materials to Design Microfluidic Chips to Remain a Major Challenge for Market Players
4.2.2. Factor Analysis
4.3. Technology Trends
4.3.1. Multiplexed Panel Detection
4.3.2. Paper-Based Microfluidics
4.4. Regulatory Analysis
4.4.1. North America
4.4.1.1. U.S.
4.4.1.2. Canada
4.4.2. Europe
4.4.3. Asia-Pacific
4.4.3.1. China
4.4.3.2. Japan
4.4.3.3. India
4.4.4. Latin America
4.4.5. Middle East
4.4.5.1. Saudi Arabia
4.5. Pricing Analysis
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Suppliers
4.6.2. Bargaining Power of Buyers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition

5. Microfluidic Immunoassay Market Assessment?by Product
5.1. Overview
5.2. Consumables
5.2.1. Cartridges
5.2.1.1. Polymer
5.2.1.2. Glass
5.2.1.3. Silicon
5.2.2. Reagents
5.3. Systems

6. Microfluidic Immunoassay Market Assessment?by Technology
6.1. Overview
6.2. Electrochemical Detection
6.3. Optical Detection

7. Microfluidic Immunoassay Market Assessment?by Application
7.1. Overview
7.2. Cardiology
7.2.1. Single Biomarker Detection
7.2.2. Multiplexed Biomarker Detection
7.3. Infectious Diseases
7.4. Oncology
7.5. Other Applications

8. Microfluidic Immunoassay Market Assessment?by End User
8.1. Overview
8.2. Pharmaceutical & Biotechnology Companies
8.3. Diagnostic Laboratories
8.4. Hospital
8.5. Other End Users

9. Microfluidic Immunoassay Market Assessment?by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.6. Middle East & Africa

10. Competition Analysis
10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies

11. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)
11.1. Abbott Laboratories
11.2. Revvity, Inc. (Formerly PerkinElmer, Inc.)
11.3. Siemens Healthineers AG.
11.4. QuidelOrtho Corporation.
11.5. Nanomix, Inc.
11.6. Becton, Dickinson and Company
11.7. Micropoint Biotechnologies Co., Ltd.
11.8. Biosurfit SA
11.9. Koninklijke Philips N.V.
11.10. NanoEnTek Inc.
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

12. Appendix
12.1. Available Customization
12.2. Related Reports



List of Figures

Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Microfluidic Immunoassay Market, by Product, 2023 Vs. 2030 (USD Million)
Figure 8 Global Microfluidic Immunoassay Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 9 Global Microfluidic Immunoassay Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 10 Global Microfluidic Immunoassay Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 11 Microfluidic Immunoassay Market, by Geography
Figure 12 Impact Analysis of Market Dynamics
Figure 13 Global Pharmaceutical R&D Expenditure, 2012–2026 (USD Billion)
Figure 14 Eu Regulatory Pathway - IVDR 2017/746
Figure 15 Porter’s Five Forces Analysis
Figure 16 Global Microfluidic Immunoassay Market, by Product, 2023 Vs. 2030 (USD Million)
Figure 17 Global Microfluidic Immunoassay Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 18 Global Microfluidic Immunoassay Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 19 Global Microfluidic Immunoassay Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 20 Global Pharmaceutical R&D Spending, 2012–2026 (USD Billion)
Figure 21 Global Microfluidic Immunoassay Market, by Region, 2023 Vs. 2030 (USD Million)
Figure 22 North America: Number of People Aged 65 Years and Above, 2015–2021 (In Million)
Figure 23 North America: Microfluidic Immunoassay Market Snapshot
Figure 24 U.S.: Pharmaceutical R&D Expenditure, 2014–2021 (USD Billion)
Figure 25 Europe: Pharmaceutical Industry R&D Expenditure, 2000–2021 (USD Million)
Figure 26 Europe: Microfluidic Immunoassay Market Snapshot
Figure 27 U.K: Estimated Number of Cancer Cases, 2020–2030
Figure 28 Pharmaceutical R&D Expenditure, by Country, 2020 (USD Million)
Figure 29 Asia-Pacific: Microfluidic Immunoassay Market Snapshot
Figure 30 Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 31 Microfluidic Immunoassay Market: Competitive Benchmarking (Based on Product)
Figure 32 Microfluidic Immunoassay Market: Competitive Benchmarking (Based on Geography)
Figure 33 Competitive Dashboard: Microfluidic Immunoassay Market
Figure 34 Abbott Laboratories: Financial Overview (2022)
Figure 35 PerkinElmer, Inc.: Financial Overview (2022)
Figure 36 Siemens Healthineers AG: Financial Overview (2022)
Figure 37 QuidelOrtho Corporation: Financial Snapshot (2022)
Figure 38 Nanomix, Inc.: Financial Overview (2022)
Figure 39 Becton, Dickinson and Company: Financial Overview (2022)
Figure 40 Koninklijke Philips N.V.: Financial Snapshot (2022)
Figure 41 NanoEnTek Inc.: Financial Snapshot (2022)